IL-17C is thought to have autocrine, inflammation-amplifying activity in disease models of psoriasis and atopic dermatitis, but in order to serve a similar role in the epithelial inflammation seen in pelvic inflammatory disease, IL-17C would need to be sensed at the epithelial lumen64. This evidence concerns the gene IL17C and atopic eczema.